Breast cancer is a heterogeneous disease, categorized clinically based on expression of hormone receptors, estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor 2 receptor (HER2) [1]. This evidence concerns the gene PGR and breast carcinoma.